BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 964 filers reported holding BAXTER INTL INC in Q3 2014. The put-call ratio across all filers is 1.07 and the average weighting 0.4%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $25,505,424 | -11.3% | 762,494 | +13.3% | 0.01% | -10.0% |
Q1 2024 | $28,762,268 | -9.5% | 672,959 | -18.2% | 0.01% | -16.7% |
Q4 2023 | $31,791,394 | +19.8% | 822,333 | +17.0% | 0.01% | +9.1% |
Q3 2023 | $26,534,956 | -45.9% | 703,099 | -34.7% | 0.01% | -45.0% |
Q2 2023 | $49,066,662 | -20.1% | 1,076,968 | -28.9% | 0.02% | -23.1% |
Q1 2023 | $61,435,948 | +29.6% | 1,514,693 | +62.8% | 0.03% | +23.8% |
Q4 2022 | $47,421,672 | -21.3% | 930,384 | -16.9% | 0.02% | -27.6% |
Q3 2022 | $60,271,000 | -8.3% | 1,119,040 | +9.3% | 0.03% | -3.3% |
Q2 2022 | $65,760,000 | -1.9% | 1,023,818 | +18.4% | 0.03% | +15.4% |
Q1 2022 | $67,029,000 | +26.6% | 864,441 | +40.2% | 0.03% | +36.8% |
Q4 2021 | $52,930,000 | -1.4% | 616,617 | -7.6% | 0.02% | -9.5% |
Q3 2021 | $53,677,000 | +0.7% | 667,377 | +0.8% | 0.02% | 0.0% |
Q2 2021 | $53,303,000 | -8.5% | 662,144 | -4.1% | 0.02% | -19.2% |
Q1 2021 | $58,242,000 | -36.0% | 690,562 | -39.1% | 0.03% | -39.5% |
Q4 2020 | $90,949,000 | -54.5% | 1,133,464 | -54.4% | 0.04% | -60.2% |
Q3 2020 | $199,780,000 | +16.7% | 2,484,205 | +24.9% | 0.11% | +6.9% |
Q2 2020 | $171,205,000 | +151.4% | 1,988,440 | +137.1% | 0.10% | +106.1% |
Q1 2020 | $68,102,000 | -5.2% | 838,798 | -2.4% | 0.05% | +19.5% |
Q4 2019 | $71,842,000 | -4.9% | 859,154 | -0.5% | 0.04% | -12.8% |
Q3 2019 | $75,505,000 | +14.4% | 863,212 | +7.1% | 0.05% | +14.6% |
Q2 2019 | $65,998,000 | -9.4% | 805,840 | -10.0% | 0.04% | -12.8% |
Q1 2019 | $72,826,000 | +22.4% | 895,659 | -0.9% | 0.05% | +6.8% |
Q4 2018 | $59,480,000 | -11.9% | 903,672 | +3.1% | 0.04% | 0.0% |
Q3 2018 | $67,541,000 | +3.0% | 876,126 | -1.4% | 0.04% | -4.3% |
Q2 2018 | $65,592,000 | +19.2% | 888,302 | +5.0% | 0.05% | +15.0% |
Q1 2018 | $55,040,000 | -1.6% | 846,247 | -2.2% | 0.04% | 0.0% |
Q4 2017 | $55,909,000 | -1.1% | 864,931 | -4.0% | 0.04% | -4.8% |
Q3 2017 | $56,553,000 | -11.1% | 901,239 | -14.3% | 0.04% | -14.3% |
Q2 2017 | $63,640,000 | +15.1% | 1,051,214 | -1.4% | 0.05% | +11.4% |
Q1 2017 | $55,285,000 | +23.5% | 1,066,040 | +5.6% | 0.04% | +18.9% |
Q4 2016 | $44,778,000 | -3.0% | 1,009,876 | +4.1% | 0.04% | -5.1% |
Q3 2016 | $46,183,000 | +3.4% | 970,226 | -1.7% | 0.04% | +2.6% |
Q2 2016 | $44,647,000 | +7.8% | 987,326 | -2.0% | 0.04% | +8.6% |
Q1 2016 | $41,403,000 | +11.9% | 1,007,854 | +3.9% | 0.04% | +12.9% |
Q4 2015 | $37,014,000 | +14.9% | 970,225 | -1.1% | 0.03% | +10.7% |
Q3 2015 | $32,211,000 | -53.4% | 980,560 | -0.7% | 0.03% | -50.9% |
Q2 2015 | $69,078,000 | +3.2% | 987,821 | +1.1% | 0.06% | +5.6% |
Q1 2015 | $66,923,000 | -7.4% | 976,985 | -1.0% | 0.05% | -10.0% |
Q4 2014 | $72,300,000 | +0.6% | 986,496 | -1.4% | 0.06% | -1.6% |
Q3 2014 | $71,837,000 | -1.8% | 1,000,938 | -1.1% | 0.06% | -1.6% |
Q2 2014 | $73,179,000 | -15.7% | 1,012,156 | -14.3% | 0.06% | -17.3% |
Q1 2014 | $86,855,000 | +22.6% | 1,180,414 | +15.9% | 0.08% | +19.0% |
Q4 2013 | $70,835,000 | -2.7% | 1,018,479 | -8.1% | 0.06% | -12.5% |
Q3 2013 | $72,815,000 | -7.4% | 1,108,465 | -2.3% | 0.07% | -13.3% |
Q2 2013 | $78,602,000 | – | 1,134,719 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Soditic Asset Management LLP | 147,620 | $7,951,000 | 9.91% |
NUANCE INVESTMENTS, LLC | 5,429,702 | $292,444,000 | 6.51% |
Endurant Capital Management LP | 245,093 | $13,201,000 | 4.30% |
Veritas Asset Management LLP | 8,589,401 | $462,625,000 | 3.83% |
GENERATION INVESTMENT MANAGEMENT LLP | 11,876,040 | $639,644,000 | 3.80% |
Sivik Global Healthcare LLC | 120,000 | $6,463,000 | 3.59% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 480,500 | $25,880,000 | 3.31% |
Integral Health Asset Management, LLC | 300,000 | $16,158,000 | 3.14% |
Boothe Investment Group, Inc. | 89,078 | $4,798,000 | 3.11% |
Glenview Capital Management | 2,257,019 | $121,563,000 | 3.04% |